作者 | 守望者 来源 | 守望核心 导语： 拆解宠物板块持续新高背后的三大预期与核心标的逻辑。 宠物板块持续新高的背后市场在交易什么预期，借助公开资料，理一下宠物板块的β及选股思路， 以及个股的核心看点 。 一、大背景 宠物经济蓬勃发展的内核是宠物的 "人格化、家人化" ， 年轻一代将宠物视为"家人"的情感价值重 构。 1、宠物经济正是基于这一情感纽带蓬勃发展，从提供高品质的宠物食品、个性化的宠物用品，满 足宠物的物质需求； 2、到宠物医疗、保险，为宠物的健康保驾护航； 3、再到宠物美容、摄影、社交活动等，满足主人与宠物之间情感互动的精神需求。 每一个细分领域，让宠物真正融入家庭生活，也让宠物经济的内涵和外延得以不断拓展和深化 。 二、宠物是一个大赛道 1、横向对比化妆品、白酒、食品等来看， 宠物赛道是消费里面少有量价齐升的板块 ，并且随着单 身经济及消费方式的转变， 从实物消费到情绪消费的转变 ，相信大家多少在家里面都多少有一些 宠物（常见的是猫、狗，稀罕的是鸟、仓鼠、乌龟、蛇等），宠物恰逢其时，目前A股从宠物食品 到医疗已经形成一个完整的贝塔。 C、主业稳健，每年贡献净利润大几千万，收购的淘通科技可以贡 ...

Core Viewpoint - The article argues that the recent performance misses of Furuai Co. are due to a misunderstanding of the industry's development pace, with the NASH (Non-Alcoholic Steatohepatitis) market set to explode following the launch of semaglutide in Q3 of this year [1][3]. Group 1: NASH Drug Launch and Fibroscan Demand - The launch of NASH drugs is expected to lead to a tenfold increase in demand for Fibroscan, the core product of EchoSens, a subsidiary of Furuai Co. [3][6]. - There are approximately 300-400 million NASH patients globally, and major pharmaceutical companies are investing in NASH drug development, with multiple new drugs expected to launch between 2025 and 2030 [2][6]. - The demand for Fibroscan will be driven by the need to identify asymptomatic NASH patients and evaluate treatment efficacy, potentially leading to over 100 million annual tests in Europe and the U.S. alone [2][6]. Group 2: Market Dynamics and Competitive Landscape - Fibroscan has no competitors in developed markets like Europe and the U.S., with patent protection extending until 2039, ensuring a long period of market exclusivity [2][15]. - The U.K. has already included Fibroscan in routine health checks, and other European countries are likely to follow suit, further increasing demand [3][15]. Group 3: Revenue Model and Growth Potential - The GO/BOX revenue-sharing model allows EchoSens to provide Fibroscan probes for free, generating income through testing fees, with potential revenues reaching €4 billion if all tests are charged at an average of €40 [13][15]. - The company aims to significantly increase the number of installed Fibroscan units, projecting an addition of 2,400 units by 2025 [13]. Group 4: Clinical Validation and Adoption - Fibroscan is the only NASH diagnostic tool recommended by clinical guidelines in the U.S., which is crucial for gaining acceptance among healthcare providers [15][16]. - Over 90% of NASH drugs in clinical trials are utilizing Fibroscan for efficacy assessment, indicating strong future demand for the technology [16].

Core Viewpoint - The rise of digital entertainment platforms such as gaming, streaming, and social media is significantly impacting alcohol consumption among younger generations, overshadowing health concerns related to drinking [1][2]. Group 1: Industry Trends - In 2023, global alcohol sales volume decreased by 1%, while sales revenue increased by 2%, indicating a shift towards higher-quality premium beverages despite reduced consumption [2]. - The Asahi Group views the changing social consumption trends as an opportunity, targeting previously overlooked demographics such as bloggers, gamers, and social media influencers to promote high-end alcoholic and low-alcohol beverages [2][3]. - The World Health Organization recommends that all alcohol products carry health warning labels similar to those on tobacco products, with Ireland set to implement this measure starting next year [2]. Group 2: Company Insights - Asahi Group's CEO, Atsushi Katsuki, believes that alcohol is not the "next tobacco product," emphasizing that unlike smoking, moderate drinking can have health benefits [3][4]. - The company has not observed any negative impact on alcohol sales from the rising popularity of weight loss medications like Ozempic, suggesting that improved health may lead to increased moderate drinking among those previously advised against it [4]. - Asahi Group's stock recently reached an all-time high, benefiting from inflation trends in Japan and the company's new shareholder return policy following debt reduction [4][5]. Group 3: Market Expansion - Despite challenges such as tariffs imposed by former U.S. President Donald Trump, Asahi Group remains optimistic about entering the U.S. market, which is currently a significant gap in its operations [5].

Group 1: Xiaomi's Response to SU7 Incident - Xiaomi's first car, SU7, was involved in a serious collision and fire incident, resulting in three fatalities, with the specific cause yet to be disclosed [4] - The incident has led Xiaomi to recognize the heightened public expectations regarding safety and responsibility, emphasizing the company's commitment to industry leadership [4] - Lei Jun's public remarks reflect Xiaomi's serious approach to automotive safety issues and a determination for self-improvement, indicating potential enhancements in future safety performance [4] - The short-term negative impact of the incident is significant, necessitating ongoing monitoring of Xiaomi's automotive safety improvements, market feedback, and sales performance to assess the long-term effects on the brand and business growth [4] Group 2: Automotive Parts Sector Trends - The automotive parts sector is entering a new valuation reconstruction cycle driven by multiple policies and technological themes, with a focus on companies that integrate "robotics + smart vehicles" [3] - Companies that can expand into a second growth curve and demonstrate actual delivery capabilities and order validation are particularly favored [3] - The new mandatory standards for light vehicle automatic emergency braking systems (AEBS) are expected to significantly increase the installation rate of AEBS [5] Group 3: Citigroup's Investment Strategy - In Q1, Citigroup significantly increased its holdings in Nvidia (+48%), Apple (+62%), and Microsoft (+76%), collectively accounting for nearly 8% of its investment portfolio, reflecting a strong bullish outlook on the tech sector driven by AI [6] - Citigroup is also heavily invested in SPDR Gold ETF call options and long-term U.S. Treasury ETF call options, indicating a strategy to hedge against macroeconomic risks such as inflation and interest rate changes [7] - Notably, Citigroup has increased its position in Nasdaq 100 put options by over 300%, with a market value of $12 billion, representing 6.12% of its total assets, highlighting a strategy to hedge against potential systemic risks, particularly in overvalued tech stocks [7] Group 4: Walmart's Pricing Strategy - Walmart's CFO announced plans to raise prices on various products starting in late May, particularly in toys, electronics, and grocery items, with June expected to be the peak for price increases [8] - This strategy may attract middle- and low-income consumers amid high inflation and weak consumption, potentially increasing Walmart's market share in grocery and essential goods, although it may pressure profit margins [8] - The consumer sentiment shows a shift, with some large items like cars experiencing a "pre-purchase wave," while other categories are seeing a wait-and-see attitude, indicating inflation expectations are significantly influencing consumer decision-making [8] Group 5: WuXi Biologics' Strategic Shift - WuXi Biologics announced the sale of its biopharmaceutical manufacturing facility in Leverkusen, Germany, for €150 million (approximately 1.21 billion RMB) to Japan's Terumo [5] - The company is reallocating resources to a large CRDMO center in Singapore, with a total investment of $1.4 billion and a planned capacity of 120,000 liters, which will become Singapore's first end-to-end biopharmaceutical service platform [5] - This restructuring reflects confidence in optimizing the Southeast Asian supply chain, policy stability, and nearshore service capabilities for global clients, while also reducing exposure to policy risks in the European and American markets [5] - The sale of the German facility allows WuXi to free up management and capital resources, transitioning to a new large integrated platform that enhances end-to-end service efficiency and client integration capabilities [5]

Core Viewpoint - The article discusses the challenges faced by Moutai 1935 in regaining its market position and price stability, particularly in the banquet market, amidst a backdrop of declining prices and increased competition [3][5]. Group 1: Market Performance - Moutai 1935, once priced at 1188 yuan per bottle at launch, saw its price peak at over 1800 yuan but has since dropped significantly, with current prices around 750 yuan, far below the 1000 yuan benchmark [7][9]. - Sales figures for Moutai 1935 were impressive initially, with over 110 billion yuan in sales in 2023 and 160 billion yuan within 700 days of launch, but prices have since fallen by approximately two-thirds [9][13]. - The decline in Moutai 1935's price has led to significant inventory issues for distributors, with many facing losses on sales [9][13]. Group 2: Strategic Initiatives - Moutai has introduced new banquet policies, including a bottle cap refund promotion and a honeymoon package for wedding events, to stimulate demand in the banquet market [4][15]. - The company is also diversifying its product offerings, including a new 1.935L bottle size, to cater to different consumer needs and enhance market competitiveness [15][16]. - Moutai's management emphasizes collaboration with other liquor companies to foster a rational consumption ecosystem and explore differentiated development paths [11][13]. Group 3: Competitive Landscape - The banquet market represents a significant opportunity, accounting for 40% of the total revenue in the liquor industry, with wedding events comprising half of this segment [16]. - Other liquor companies, such as Guotai and Wuliangye, are also aggressively targeting the banquet market, indicating a highly competitive environment [17]. - The shift from price competition to scenario-based competition highlights the evolving dynamics within the liquor industry, making it challenging for Moutai 1935 to regain its former market position [17].

Core Viewpoint - The article discusses the complex interrelationships within the lithium battery supply chain, particularly focusing on the deep ties between Ningde Times and Xingyun Co., highlighting how these relationships influence financial performance and investment strategies [2][4]. Group 1: Financial Dynamics - Ningde Times plans to raise approximately HKD 30.7 billion, with about 90% allocated for projects in Hungary, which may involve equipment procurement from Xingyun Co. [5] - Xingyun Co. recently completed a private placement raising about CNY 637 million, primarily for building a storage system and battery component manufacturing center in Ningde, closely tied to Ningde Times [7]. - Despite Xingyun Co. reporting a net loss of CNY 97.45 million in 2024 and over CNY 10 million in Q1 2025, its stock price increased by nearly 50% shortly after the private placement [11]. Group 2: Strategic Relationships - The capital interlock between Xingyun Co. and Ningde Times is evident, with significant investments from Ningde Times' affiliates in Xingyun's private placement, indicating a mutual benefit in their financial dealings [9][11]. - Xingyun Co.'s revenue heavily relies on Ningde Times, with 60.02% of its total revenue in 2022 coming from Ningde Times and its subsidiaries [12]. - The relationship extends beyond financial transactions, as key executives from both companies share personal and professional connections, enhancing collaboration opportunities [17][18]. Group 3: Market Position and Challenges - Xingyun Co. has faced declining profitability, with gross margins dropping from 45% in 2021 to 28% in 2022, and accounts receivable turnover days increasing significantly [14]. - The joint venture, Fujian Times Xingyun Technology, aimed at the "light-storage-charging-inspection" market, has struggled to achieve profitability despite growing revenues [19]. - New regulations mandating safety inspections for power batteries may create new business opportunities for Xingyun Co., potentially offsetting previous losses [21].

Core Viewpoint - The article discusses the IPO of Hangzhou Tongshifu Cultural (Group) Co., Ltd. ("Tongshifu"), highlighting its unique position in the copper cultural product market and its growth potential as it prepares for listing on the Hong Kong Stock Exchange [1]. Company Background - Tongshifu was founded by Yu Guang, who identified a gap in the market for high-quality, cost-effective copper art pieces after struggling to find a suitable gift [3]. - The company combines traditional craftsmanship with modern aesthetics, utilizing a unique high-temperature coloring and painting process to create durable copper art products [4]. Market Position and Strategy - Tongshifu has adopted a strategy of offering "artistic quality at industrial prices," catering to a wide range of consumers with products priced from 39 RMB to 39,999 RMB [4]. - The company has achieved significant brand recognition through successful crowdfunding campaigns and collaborations with major brands, including a partnership with Warner Bros. [5]. Financial Performance - The company has seen steady revenue growth, with revenues of 503.2 million RMB in 2022, 506.4 million RMB in 2023, and an estimated 571.2 million RMB in 2024, reflecting a compound annual growth rate (CAGR) of 6.54% [8]. - Net profits have also increased, with figures of 57 million RMB, 44.1 million RMB, and an estimated 79.8 million RMB for the respective years, showing a CAGR of 17.78% [8]. Sales Channels and Market Share - Online sales accounted for a significant portion of total revenue, with 80.9%, 79.2%, and 77.2% from 2022 to 2024, respectively [9]. - Tongshifu ranks first in the copper cultural product category on major e-commerce platforms like Tmall and JD.com [9]. Intellectual Property and Innovation - The company has developed a robust intellectual property portfolio, with 1,575 copyrights and various patents, enhancing its competitive edge [7]. - R&D expenditures have been consistent, representing 3.7%, 5.7%, and 4.9% of total revenue during the reporting period, focusing on original design and process improvements [11]. Challenges and Risks - Despite its market leadership, Tongshifu faces challenges from emerging brands and increasing competition, with the top three companies holding 71.9% of the market share [11]. - The company relies heavily on copper for its products, which constitutes over 51.9% of total operating costs, exposing it to fluctuations in copper prices [12]. - The revenue structure is relatively narrow, with over 95% coming from copper products, indicating potential risks associated with market dependency [12].

Core Viewpoint - The sentiment of retail investors is not significant for Ningde Times, which prefers long-term institutional investors for its IPO [1][10][18]. Group 1: IPO Details - Ningde Times' IPO in Hong Kong has seen strong institutional interest, with total orders exceeding $50 billion, equivalent to approximately 390.3 billion HKD, and an oversubscription rate of 30 times after excluding cornerstone subscriptions [1][17]. - The IPO price was set at 263 HKD per share, with retail subscriptions exceeding 117 times, amounting to over 270 billion HKD [1][3]. - The company has applied for a waiver from the Hong Kong Stock Exchange, allowing it to limit retail participation to 7.5% of the total offering, regardless of oversubscription levels [7][10][21]. Group 2: Institutional vs Retail Interest - There is a notable disparity in the enthusiasm between institutional and retail investors, with retail subscriptions for Ningde Times being significantly lower compared to other recent IPOs like Mixue Ice Cream, which had a retail oversubscription of 5258.21 times [3][4]. - The preference for institutional investors is reflected in the IPO structure, which aims to attract long-term holders rather than short-term retail traders [5][20]. - The company has engaged over 20 cornerstone investors, including both foreign and domestic institutions, who are required to lock in their shares for at least six months [20][11]. Group 3: Market Dynamics and Future Implications - The trend indicates a gradual marginalization of retail investors in the Hong Kong market, with their participation in total trading volume dropping below 15% [14][19]. - The recent reforms proposed by the Hong Kong Stock Exchange aim to reduce the allocation of shares to retail investors, which could further diminish their role in future IPOs [21][23]. - The overall sentiment among institutional investors remains high, with expectations of significant price appreciation upon listing, potentially around 10% on the first day [18][22].

Core Viewpoint - The article discusses the controversial nature of the "Zhongminbao" health insurance product launched by Zhong An Insurance, highlighting its attractive pricing and relaxed underwriting standards, which have raised concerns about potential losses for the company [2][5][10]. Summary by Sections Product Features - Zhongminbao offers unique features such as coverage for pre-existing conditions, the ability to purchase insurance up to the age of 105, and a zero deductible, which have garnered significant attention in the market [4][10]. - The product has achieved over 100 million in sales within ten days of its launch, indicating strong market demand [4]. Market Dynamics - The health insurance market is experiencing a shift, with increasing demand for high-end medical resources following reforms in medical insurance payment systems [9]. - Zhongminbao's pricing is approximately 40% lower than similar products, making it highly competitive in the market [10]. Risks and Concerns - The relaxed underwriting criteria may attract a higher number of high-risk clients, leading to potential future losses for Zhong An Insurance if claims exceed expectations [12]. - There is a lack of clarity regarding the definitions of "general pre-existing conditions" versus "serious pre-existing conditions," which could lead to disputes over claims [14]. Strategic Importance - Zhong An Insurance's move into the health insurance sector is seen as a strategic shift, as other lines of business have not been profitable [17]. - The company aims to reduce its reliance on online platforms and improve its cost structure through the introduction of Zhongminbao [21][22]. Market Positioning - The product targets a middle-income demographic that has a growing need for commercial health insurance, particularly among individuals around 40 years old [23]. - Zhongminbao is positioned as a potential solution for Zhong An Insurance to escape the cycle of high customer acquisition costs and low profitability associated with its previous offerings [19][20].

Core Viewpoint - The recent incident involving a "bloody zongzi" has cast a shadow over the zongzi market, potentially impacting the sales of both Laiyifen and Wufangzhai during the upcoming Dragon Boat Festival [1][4]. Company Responses - Laiyifen has actively engaged with consumers, promising to cover any medical expenses arising from the incident and has taken measures to withdraw the affected batch of products from the market [6]. - Wufangzhai has stated that they follow strict internal protocols to prevent contamination, including the use of specialized bandages for employees [6]. Market Impact - The incident could adversely affect the sales of both companies during the peak zongzi season, particularly for Wufangzhai, which relies heavily on zongzi for revenue [9]. - Wufangzhai's zongzi sales accounted for over 70% of its revenue in recent years, with the second quarter being crucial, contributing to over 60% of annual income [9]. Financial Performance - Wufangzhai's zongzi revenue for 2024 was reported at 1.579 billion yuan, a decrease of 361 million yuan compared to the previous year, marking the lowest level since 2019 [9]. - The overall revenue for Wufangzhai in the previous year was 2.251 billion yuan, reflecting a year-on-year decline of 14.57%, the worst performance since public disclosures began in 2018 [9]. Company Strategies - Laiyifen has been struggling with performance, reporting a 15.25% decline in revenue to 3.370 billion yuan last year, with a net loss of 75.27 million yuan [10]. - The company has attempted to diversify its offerings by entering new markets such as sauces, sparkling water, and coffee, but these efforts have not yielded significant results [10]. - Laiyifen is now pursuing a "Laiyifen 2.0" strategy, aiming to create a community lifestyle platform that integrates various consumer goods beyond snacks [10][11]. Store Expansion - Laiyifen's ambitious "Wanjia Denghuo" strategy aimed for over 10,000 stores by 2023, but as of 2024, the number of stores has decreased to 3,085, down by 600 from the beginning of the year [11].